Floatz logo

MELOXIDOLOR

Biliary Atresia, Kasai Portoenterostomy Status

Yonsei UniversitySmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Biliary Atresia, Kasai Portoenterostomy Status cohort.

Asset / SponsorPhaseRating
Pentoxifylline
Baylor College of Medicine
Phase 2CCC
Vancomycin
Sacramento Pediatric Gastroenterology
Phase 1CC
NEOMYCIN
National Taiwan University Hospital
N/AD
CEFACLOR ANHYDROUS
Children's Hospital of Fudan University
N/AD
IMIPENEM
Children's Hospital of Fudan University
N/AD

View all 11 →

Same molecule, other indications

MELOXIDOLOR is also rated in:

migraine disorderDormant
B
Indicative ·
60 / 100
View asset →
prostate neoplasmDormant
B
Indicative ·
57 / 100
View asset →
non-Hodgkin lymphomaDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →